gene therapy (GPC Biotech)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namegene therapy (GPC Biotech)
Drug Alias Namegene therapy (GPC Biotech/Cell Genesys)gene therapy (Mitotix/Cell Genesys)AV-W9
ClassificationBiologics
Mechanisms of ActionCell cycle inhibitors
TargetsUpdating
Therapy Area/IndicationsCoronary RestenosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAgennix Usa Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCold Spring Harbor LaboratoryGpc BiotechBiosante Pharmaceuticals Inc +[6] 
Active IndicationsN/A
Inactive IndicationsCoronary RestenosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A